W. Buchanan

W. Buchanan, J. Sharma, Jagdish N. Sharma, 1994, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Sjogren's syndrome. I. Sicca components.

W. Buchanan, K. Whaley, D. Chisholm, 1973, The Quarterly journal of medicine.

Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication.

R. Stevenson, W. Buchanan, P. Brooks, 1976, The Journal of rheumatology.

Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy

W. Buchanan, S. Campbell, J. A. Boyle, 1966, Journal of clinical pathology.

Serum uric acid-its relationship to lean body mass sex, plasma urea, intracellular potassium and packed cell volume in a normal population group.

J. Anderson, W. Buchanan, P. Brooks, 1975, Annals of the Rheumatic Diseases.

The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.

W. Buchanan, W. Dick, R. Pumphrey, 1977, Australian and New Zealand journal of medicine.

CLINICAL, PATHOLOGIC, AND SEROLOGIC STUDIES IN SJOEGREN'S SYNDROME; COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

J. S. Beck, W. Buchanan, J. J. Bunim, 1964, Annals of internal medicine.

Immunogenetics of psoriatic arthritis.

W. Buchanan, D. Singal, K. Al-jarallah, 1993, Immunological investigations.

Depression in rheumatoid arthritis.

W. Buchanan, W. Dick, E. Robinson, 1977, The Journal of the Royal College of General Practitioners.

William Heberden the elder (1710–1801): thecompleat physician and sometime rheumatologist

W. Buchanan, W. Kean, 1987, Clinical Rheumatology.

Antirheumatic Drugs: Clinical Pharmacology and Therapeutic Use

W. Buchanan, G. Craig, Dr Gary L. Craig, 1980, Drugs.

Rheumatic complications of alcohol abuse.

W. Buchanan, D. Shehab, K. Al-jarallah, 1992, Seminars in arthritis and rheumatism.

Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

W. Buchanan, W. Dick, G. Bálint, 1978, Postgraduate medical journal.

Indomethacin--aspirin interaction: a clinical appraisal.

W. Buchanan, P. Brooks, J. Walker, 1975, British medical journal.

Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.

W. Buchanan, G. Hughes, W. Dick, 1977, Annals of the rheumatic diseases.

Relative roles of genetic and environmental factors in control of blood pressure in normotensive subjects.

W. Downie, W. Buchanan, J. A. Boyle, 1969, British heart journal.

subjects . blood pressure in normotensive environmental factors in control of Relative roles of genetic and

W. Downie, W. Buchanan, J. A. Boyle, 2022 .

STUDIES OF THE RISE IN PLASMA 11-HYDROXYCORTICOSTEROIDS (11-OHCS) IN CORTICOSTEROID-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS DURING SURGERY: CORRELATIONS WITH THE FUNCTIONAL INTEGRITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS

W. Buchanan, J. A. Boyle, M. K. Jasani, 1968 .

Plasma corticosteroids in healthy twin pairs.

W. Buchanan, J. A. Boyle, W. Greig, 1969, Journal of medical genetics.

In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

W. Buchanan, P. Rooney, 1990, Clinical Rheumatology.

Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy.

W. Buchanan, J. A. Boyle, W. Dick, 1968, Annals of the rheumatic diseases.

Recent Progress in Arthritis

W. Buchanan, M. K. Jasani, W. Watson Buchanan, 1967 .

MONTH OF BIRTH AND RHEUMATOID ARTHRITIS

W. Buchanan, H. Buchanan, L. Gregoire, 1987, The Lancet.

Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study.

W. Downie, W. Buchanan, P. Brooks, 1976, Annals of the rheumatic diseases.

Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique.

W. Downie, W. Buchanan, J. A. Boyle, 1970, Annals of the rheumatic diseases.

Dietes mellitus and gout. Blood sugar and plasma insulin responses to oral glucose in normal weight, overweight, and gouty patients.

W. Buchanan, J. A. Boyle, K. Buchanan, 1969, Annals of the rheumatic diseases.

Gold toxicity: chemical, structural, biological and clinical experimental issues

W. Buchanan, W. Kean, C. Lock, 1992 .

The effect of the thermal mineral water of Nagybaracska on patients with knee joint osteoarthritis—a double blind study

W. Buchanan, G. Bálint, P. Bálint, 2007, Clinical Rheumatology.

Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls

W. Buchanan, E. Tunks, W. Kean, 1989, Clinical Rheumatology.

Kinin system in clinical and experimental rheumatoid inflammation: a short review.

W. Buchanan, J. Sharma, 1979, Current medical research and opinion.

Pharmacological and Pharmacodynamic Implications of Nonsteroidal Anti-Inflammatory Drug Therapy in Elderly Arthritic Patients

W. Buchanan, 1990 .

Bone loss in patients with rheumatoid arthritis.

W. Buchanan, M. K. Jasani, J. Anderson, 1975, Scandinavian journal of rheumatology.

Rheumatoid hand weakness characterising indices and clinical data acquisition.

P. Tugwell, W. Buchanan, D. Ghista, 1984, Engineering in medicine.

THE ACTION OF ASPIRIN ON PLASMA KININOGEN AND OTHER PLASMA PROTEINS IN RHEUMATOID PATIENTS: RELATIONSHIP TO DISEASE ACTIVITY

W. Buchanan, P. Brooks, W. Dick, 1980, Clinical and experimental pharmacology & physiology.

Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.

D. H. Brown, W. Buchanan, J. Teape, 1979, Annals of the rheumatic diseases.

A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis.

W. Buchanan, W. Stephens, M. Macleod, 1979, Current medical research and opinion.

A short-term comparative trial of salsalate and indomethacin in rheumatoid arthritis.

W. Buchanan, W. Dick, S. Deodhar, 1977, Current medical research and opinion.

Mefenamic acid: an under-rated antirheumatic?

W. Buchanan, M. Mavrikakis, J. Rennie, 1977, Current medical research and opinion.

Comparison of sulindac and aspirin in rheumatoid arthritis.

W. Buchanan, P. Reynolds, M. Macleod, 1977, Current medical research and opinion.

An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis.

J. Anderson, W. Buchanan, P. Brooks, 1976, Current medical research and opinion.

Relationship between haemoglobin and the other clinical and laboratory parameters in rheumatoid arthritis.

J. Anderson, W. Buchanan, W. Dick, 1975, Current medical research and opinion.

Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

W. Downie, W. Buchanan, K. Whaley, 1973, Annals of the rheumatic diseases.

Clinical studies on inflammation in human knee joints: xenon (133Xe) clearances correlated with clinical assessment in various arthritides and studies on the effect of intra-articularly administered hydrocortisone in rheumatoid arthritis.

W. Downie, W. Buchanan, J. A. Boyle, 1970, Clinical science.

Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity.

W. Downie, W. Buchanan, M. K. Jasani, 1968, Annals of the rheumatic diseases.

Effect of synovectomy on the clearance of radioactive xenon (133Xe) from the knee joint of patients with rheumatoid arthritis.

W. Buchanan, K. Whaley, W. Dick, 1970, The Journal of bone and joint surgery. British volume.

Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965.

W. Buchanan, J. J. Bunim, K. Bloch, 1992, Medicine.

Observations on Drug Prescribing in Rheumatoid Arthritis

W. Buchanan, P. Brooks, P. Lee, 1974, British medical journal.

Salivary flow rates and iodide trapping capacity in patients with Sjögren's syndrome.

W. Buchanan, J. A. Boyle, R. Harden, 1967, Annals of the rheumatic diseases.

Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.

W. Buchanan, W. Dick, J. Williamson, 1977, The New Zealand medical journal.

Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE.

W. Buchanan, W. Dick, M. Mavrikakis, 1977, The New Zealand medical journal.

A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index.

N. Bellamy, W. Buchanan, J. Campbell, 1994, The Journal of rheumatology.

Nocturnal pain correlates with effusions in diseased hips.

W. Buchanan, G. Bálint, P. Bálint, 1992, The Journal of rheumatology.

Low dose cyclosporine in rheumatoid arthritis: a pilot study.

P. Tugwell, C. Bombardier, N. Bellamy, 1987, The Journal of rheumatology.

Methotrexate in Rheumatoid Arthritis: Impact on Quality of Life Assessed by Traditional Standard-Item and Individualized Patient Preference Health Status Questionnaires

M. Guttadauria, P. Tugwell, C. Bombardier, 1990 .

Y box-binding trans-regulatory nuclear proteins and susceptibility to rheumatoid arthritis.

W. Buchanan, D. Singal, H. Fleisig, 1996, Clinical and experimental rheumatology.

Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.

W. Buchanan, W. Kean, C. Lock, 1982, Arthritis and rheumatism.

Sjøgren's SyndromeI. SICCA COMPONENTS

W. Buchanan, K. Whaley, D. Chisholm, 1973 .

Immunological responses in Sjogren's syndrome and rheumatoid arthritis.

W. Buchanan, R. N. Macsween, K. Whaley, 1971, Clinical and experimental immunology.

Sjogren's syndrome. 2. Clinical associations and immunological phenomena.

W. Buchanan, R. N. Macsween, G. Hughes, 1973, The Quarterly journal of medicine.

Pharmacokinetics of isoxicam in the elderly.

W. Buchanan, E. Grace, 1985, The American journal of medicine.

Pharmacokinetics of lsoxicam in the Elderly

W. Buchanan, E. Grace, 1985 .

Is there a need to reclassify adult rheumatoid arthritis?

W. Buchanan, D. Singal, 1990, British journal of rheumatology.

Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases

W. Buchanan, K. Rainsford, W. Kean, 2015 .

Measurement of joint inflammation. A radioisotopic method.

W. Buchanan, K. Whaley, W. Dick, 1970, Annals of the rheumatic diseases.

The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium.

A. Pack, W. Downie, W. Buchanan, 1968, Clinical science.

Infra-red surface thermography. Evaluation of a new radiometry instrument for measuring skin temperature over joints

M. H. Arnold, W. Buchanan, S. J. Preston, 1989, Clinical Rheumatology.

Prediction of organ system toxicity with antirheumatic drug therapy

W. Buchanan, P. Brooks, 1991 .

Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis.

W. Buchanan, W. Dick, S. Deodhar, 1973, The Quarterly journal of medicine.

The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function

W. Buchanan, J. Kelton, J. Gauldie, 1984 .

Rheumatoid arthritis: another New World disease?

W. Buchanan, 1994, Seminars in arthritis and rheumatism.

Frostbite arthritis consequence of first papal visit to Scotland?

W. Buchanan, 1987, Clinical Rheumatology.

NSAIDs: Clinical efficacy and toxicity

N. Bellamy, W. Buchanan, Nicholas Bellamy, 1991, InflammoPharmacology.

Nicholas Culpeper's physick for rheumatics

W. Buchanan, 2005, Clinical Rheumatology.

The Placebo Response: Clinical Efficacy and Toxicity

N. Bellamy, W. Buchanan, 1997 .

Recent advances in rheumatology

W. Buchanan, W. Dick, 1976 .

Rheumatoid arthritis as seen through long-distance spectacles

W. Buchanan, W. Kean, 2001, InflammoPharmacology.

Therapeutic effectiveness of paracetamol in rheumatoid arthritis.

J. Anderson, W. Buchanan, P. Lee, 1975, International journal of clinical pharmacology and biopharmacy.

Antithrombin activity of gold sodium thiomalate

W. Buchanan, Y. Kassam, W. Kean, 1984, Clinical pharmacology and therapeutics.

The history of gold therapy in rheumatoid disease.

W. Buchanan, Y. Kassam, P. Rooney, 1985, Seminars in arthritis and rheumatism.

Assessment of antirheumatic activity in man.

N. Bellamy, W. Buchanan, 1990, Bailliere's clinical rheumatology.

Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets.

W. Buchanan, W. Kean, C. Lock, 1989, Journal of pharmaceutical sciences.

Distribution of gold in human platelets after in-vitro interaction and during chrysotherapy with gold sodium thiomalate

W. Buchanan, G. Simon, Y. Kassam, 1992, InflammoPharmacology.

Action of gold sodium thiomalate on experimental thrombosis in vivo.

W. Buchanan, Y. Kassam, W. Kean, 1991, Journal of pharmaceutical sciences.

Disease-modifying drugs series editor : T. PULLAR AURANOFIN

W. Buchanan, W. Kean, L. Hart, 1997 .

The use of NSAIDs in rheumatic disorders 2005: a global perspective

W. Buchanan, W. Kean, 2005, InflammoPharmacology.

Osteoarthritis IV: Clinical therapeutic trials and treatment

W. Buchanan, W. Kean, 2002, InflammoPharmacology.

Antirheumatic drug therapy in the elderly

W. Buchanan, W. Kean, W. Buchanan, 1992 .

A biological effect on platelets by the minor component of gold sodium thiomalate--a by-product of heat sterilization and exposure to light.

W. Buchanan, Y. Kassam, P. Rooney, 1984, Clinical and experimental rheumatology.

Prediction of the clinical efficacy of and intolerance to antirheumatic drug therapy

W. Buchanan, P. Brooks, 1991 .

Implications of NSAID therapy in elderly patients.

W. Buchanan, 1990, The Journal of rheumatology. Supplement.

Sir William Osler (1849-1919): His Opinion of Modern Therapeutics

W. Buchanan, G. Bálint, W. Kean, 2006, Scottish medical journal.

Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.

P. Tugwell, C. Bombardier, W. Buchanan, 1988, Transplantation proceedings.

Sjögren's syndrome and autoimmunity in a geriatric population.

W. Buchanan, R. N. Macsween, G. Hughes, 1972, Age and ageing.

Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

W. Buchanan, R. N. Macsween, K. Whaley, 1975, Annals of the rheumatic diseases.

Outcome measurement in osteoarthritis clinical trials: The case for standardisation

N. Bellamy, W. Buchanan, 1984, Clinical Rheumatology.

Evidence of rheumatoid arthritis in ancient India.

W. Buchanan, R. Sturrock, J. Sharma, 1977, Arthritis and rheumatism.

Problems of Antiarthritic Therapy in the Elderly

W. Buchanan, P. Brooks, Y. Kassam, 1984, Journal of the American Geriatrics Society.

Gold induced thrombocytopenia: 12 cases and a review of the literature.

P. Tugwell, W. Buchanan, P. Powers, 1987, Seminars in arthritis and rheumatism.

Radioisotope study of small joint inflammation in rheumatoid arthritis.

W. Buchanan, K. Whaley, W. Dick, 1971, Annals of the rheumatic diseases.

Clinical associations of fibroblast growth promoting factor in scleroderma.

W. Buchanan, J. Bienenstock, S. Potter, 1984, Journal of Rheumatology.

Poor quality of posts in clinical rheumatology: a cause of failure to advance the specialty.

W. Buchanan, W. Dick, R. Sturrock, 1976, British medical journal.

Recent advances in Sjogren's syndrome.

W. Buchanan, K. Whaley, 1971, Modern trends in rheumatology.

Sjogren's syndrome: its clinical manifestations and associations.

W. Buchanan, K. Whaley, W. Dick, 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Sialographic abnormalities in Sjogren's syndrome, rheumatoid arthritis, and other arthritides and connective tissue diseases. A clinical and radiological investigation using hydrostatic sialography.

W. Buchanan, K. Whaley, D. Chisholm, 1972, Clinical radiology.

Evaluation of a functional index in rheumatoid arthritis.

W. Buchanan, M. K. Jasani, W. Dick, 1973, Scandinavian journal of rheumatology.

The arthritis of Mary Queen of Scots: Due to Marfan's syndrome?

W. Buchanan, 1986, Clinical Rheumatology.

Rheumatoid arthritis: an example of ecological succession?

W. Buchanan, R. Laurent, 1990, Canadian bulletin of medical history = Bulletin canadien d'histoire de la medecine.

Lowering of plasma isoxicam concentrations with acetylsalicylic acid.

W. Buchanan, E. Grace, J. Rosenfeld, 1986, The Journal of rheumatology.

14 – The introduction of new non-steroidal anti-inflammatory drugs

W. Buchanan, P. Brooks, 1985 .

Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis.

J. Anderson, W. Buchanan, P. Lee, 1976, The Journal of rheumatology.

Aspirin versus the non-acetylated salicylates.

W. Buchanan, K. Rainsford, 1990, Bailliere's clinical rheumatology.

Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial.

W. Buchanan, S. Gibson, R. Gibson, 1980, British journal of clinical pharmacology.

A legacy for rheumatology from Sir William Osler

W. Buchanan, G. Bálint, P. Rooney, 1987, Clinical Rheumatology.

Osteoarthritis I: Epidemiological risk factors and historical considerations

W. Buchanan, W. Kean, 2002, InflammoPharmacology.

History and current status of osteoarthritis in the population

W. Buchanan, R. Kean, W. Kean, 2004, InflammoPharmacology.

The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function.

W. Buchanan, J. Kelton, J. Gauldie, 1984, Blood.

The effect of thymoxamine on peripheral blood vessels as monitored by the 133Xe clearance technique

W. Buchanan, W. Dick, C. Provan, 1971, The Journal of pharmacy and pharmacology.

Ultrasonography after hip arthroplasty

W. Buchanan, G. Bálint, P. Bálint, 2004, Skeletal Radiology.

Penetration of lincomycin ('Lincocin') and clindamycin ('Dalacin C') into the synovial cavity in rheumatoid arthritis.

W. Buchanan, W. Dick, G. Nuki, 1972, Current medical research and opinion.

Ultrasound-guided aspiration in suspected sepsis of resection arthroplasty of the hip joint

W. Buchanan, G. Bálint, P. Bálint, 1995, Clinical Rheumatology.

Indices of inflammatory activity. Relationship between isotope studies and clinical methods.

W. Buchanan, W. Dick, G. Nuki, 1970, Annals of the rheumatic diseases.

Human leucocyte antigens (HLA) and rheumatic disease: HLA class i antigen-associated diseases

W. Buchanan, D. Singal, K. Al-jarallah, 1993, InflammoPharmacology.

Dermatoglyphic differences in determination of dizygosity diagnosis.

W. Buchanan, J. A. Boyle, W. Greig, 1969, Journal - Forensic Science Society.

Ankylosing spondylitis: yesterday and today.

W. Buchanan, R. Sturrock, D. Spencer, 1980, Medical History.

Reiter's Syndrome Re-Evaluated

W. Buchanan, D. Smith, S. Papazoglou, 1979, Scottish medical journal.

Statistical reappraisal of the clinical significance of nail beading in rheumatoid arthritis.

N. Bellamy, W. Buchanan, E. Grace, 1985, Annals of the rheumatic diseases.

HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.

D. Gladman, W. Buchanan, D. Singal, 1992, Annals of the rheumatic diseases.

Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria.

W. Buchanan, W. Bensen, D. Singal, 1990, Annals of the rheumatic diseases.

Immunogenetics of polymyalgia rheumatica.

W. Buchanan, D. Singal, K. Al-jarallah, 1993, Clinical and Experimental Rheumatology.

Osteoarthritis III: Radiological and clinical definition

W. Buchanan, W. Kean, 2002, InflammoPharmacology.

Osteoarthritis: symptoms, signs and source of pain

W. Buchanan, R. Kean, W. Kean, 2004, InflammoPharmacology.

HLA-D region antigens in patients with rheumatoid arthritis.

D. Gladman, W. Buchanan, C. Mccusker, 1991, Arthritis and rheumatism.

Episcleritis and scleritis

J. Forrester, W. Buchanan, R. N. Macsween, 2004 .

ACADEMIC MEDICINE IN CRISIS

W. Buchanan, P. Brooks, 1988, The Lancet.

Scintiscanning in ankylosing spondylitis: a clinical, radiological and quantitative radioisotopic study.

W. Buchanan, P. Horton, F. G. Adams, 1979, Journal of Rheumatology.

Perception--a problem in the grading of sacro-iliac joint radiographs.

N. Bellamy, W. Buchanan, P. Brooks, 1984, Scandinavian journal of rheumatology.

The detection of spinal pseudarthrosis in ankylosing spondylitis.

W. Buchanan, I. McCall, W. M. Park, 1981, The British journal of radiology.

Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27.

W. Buchanan, H. Dick, W. M. Park, 1979, The Journal of rheumatology.

Clinical studies on inflammation in small diarthrodial joints. Technetium ( 99m Tc) percentage uptakes in various arthritides and studies on the effect of aspirin in rheumatoid arthritis.

W. Buchanan, W. Dick, K. E. Collins, 1972, Clinical science.

Synovial perfusion of clinically normal knee joints in patients with rheumatoid arthritis. An isotope study.

W. Buchanan, W. Dick, G. Nuki, 1970, Annals of the Rheumatic Diseases.

The economics of arthritis.

W. Buchanan, G. Nuki, R. Brooks, 1972, Bulletin of rheumatic diseases.

Sir Benjamin Collins Brodie (1783-1862).

W. Buchanan, 2003, JAMA.

Clinical evaluation of two daily doses of naproxen and indomethacin: result of a double-blind crossover trial

W. Buchanan, D. Palmer, D. Grennan, 1975 .

Towards rationalisation of health-care delivery to rheumatic sufferers

W. Buchanan, W. Kean, 1983, Clinical Rheumatology.

Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis

W. Buchanan, E. Beller, J. Webb, 1990, Clinical Rheumatology.

Otolaryngological Aspects of Sjögren's Syndrome

W. Buchanan, K. Whaley, W. Dick, 1971, British medical journal.

Sir William Osler of Dundas

W. Buchanan, 1990, Journal of the Royal Society of Medicine.

Double-blind randomized controlled trial of isoxicam vs piroxicam in elderly patients with osteoarthritis of the hip and knee.

N. Bellamy, W. Buchanan, E. Grace, 1986, British journal of clinical pharmacology.

Osteoarthritis II: Pathology and pathogenesis

W. Buchanan, W. Kean, 2002, InflammoPharmacology.

Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase.

W. Buchanan, D. Sauder, A. Patel, 1991, Journal of the American Academy of Dermatology.

Comparison of the natural history of untreated acute gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs.

W. Buchanan, S. J. Preston, M. Arnold, 1988, British journal of clinical pharmacology.

European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.

W. Buchanan, Y. Kassam, 1986, The American journal of medicine.

Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride.

W. Buchanan, G. Nuki, K. Boddy, 1975, Annals of the rheumatic diseases.

Suppression by dexamethasone of the plasma cortisol response to insulin-induced hypoglycaemia

W. Downie, W. Buchanan, M. Bell, 1976 .

Serum uric acid values in various states of thyroid function.

W. Buchanan, J. A. Boyle, W. Greig, 1966, Acta rheumatologica Scandinavica.

Sulphasalazine and aminosalicylates in rheumatoid and related arthropathies

W. Buchanan, K. Rainsford, 1993, InflammoPharmacology.

Clinical trial methodology in rheumatoid arthritis: azapropazone studies

N. Bellamy, W. Buchanan, 1989 .

Clinical therapeutic trial of sodium meclofenamate and naproxen in rheumatoid arthritis, with comments on the use of placebos in clinical trials.

W. Buchanan, E. Grace, P. Rooney, 1983, Current medical research and opinion.

Serum uric acid in England and Scotland.

W. Buchanan, J. Scott, A. Kennedy, 1977, Annals of the rheumatic diseases.

Rehabilitation: The International State of the Art

W. Buchanan, P. Rooney, Kraag Gr, 1979 .

Rheumatoid Arthritis: Some Personal Considerations on Aetiology and Treatment Part 1

W. Buchanan, W. Kean, 1983, The British journal of clinical practice.

Rheumatoid Arthritis: Some Personal Considerations on Treatment Part II

W. Buchanan, W. Kean, 1983, The British journal of clinical practice.

Serum uric acid levels in England and Scotland.

W. Buchanan, J. Scott, A. Kennedy, 1977, Advances in experimental medicine and biology.

Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs.

W. Downie, N. Bellamy, W. Buchanan, 1987, British journal of clinical pharmacology.

Clinical judgement and evidence-based medicine.

W. Buchanan, W. Kean, W. Buchanan, 2001, Joint, bone, spine : revue du rhumatisme.

Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter study.

W. Buchanan, R. Élie, W. Kean, 1991, Journal of Rheumatology.

A comparison of flurbiprofen and naproxen in the treatment of rheumatoid arthritis: a Canadian multi-centre study.

W. Buchanan, H. Tannenbaum, A. Fitzgerald, 1990, Current medical research and opinion.

Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in rheumatoid arthritis.

W. Buchanan, W. Dick, D. Hole, 1979, The Journal of rheumatology.

Antirheumatic Drug Therapy in the Elderly: A Case of Failure to Identify the Correct Issues?

W. Buchanan, W. Kean, 1987, Journal of the American Geriatrics Society.

The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease.

L. Chambers, P. Tugwell, W. Buchanan, 1982, The Journal of rheumatology.

Current Topics in Connective Tissue Diseases

W. Buchanan, 1975 .

Preference for endpoint measures in clinical trials: results of structured workshops.

P Tugwell, P. Tugwell, C. Bombardier, 1982, The Journal of rheumatology.

Grading of tenderness as a source of interrater error in the Ritchie articular index.

P. Tugwell, W. Buchanan, D. Southwell, 1985, The Journal of rheumatology.

A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee

N. Bellamy, W. Buchanan, Dr. N. Bellamy, 1986, Clinical Rheumatology.

Rheumatology beyond 2000: wither or whither?

W. Buchanan, P. Brooks, 1989, Annals of the rheumatic diseases.

Pharmacokinetics of NSAID with special reference to the elderly.

W. Buchanan, W. Kean, 1987, Singapore medical journal.

Early Contributions to the Study of Bone and Joint Disease in Glasgow, Scotland

W. Buchanan, 1999, Clinical Rheumatology.

Studies on the sympathetic control of normal and diseased synovial blood vessels: the effect of alpha and beta receptor stimulation and inhibition, monitored by the 133xenon clearance technique.

W. Buchanan, K. Whaley, W. Dick, 1971, Clinical science.

Auranofin.

W. Buchanan, W. Kean, L. Hart, 2020, British journal of rheumatology.

Study of serum lipid levels in twins.

W. Buchanan, J. A. Boyle, W. Greig, 1968, Cardiovascular research.

Osteoarthritis.

W. Buchanan, K. Rainsford, W. Kean, 2023, Inflammopharmacology.

Plasma immunoglobulin concentrations in twins.

W. Buchanan, J. A. Boyle, D. Rowe, 1968, Clinical and experimental immunology.

The effects of prostaglandins PGE1, PGE2, PGF1a, and PGF2alpha on canine synovial perfusion.

W. Buchanan, W. Dick, I. J. Zeitlin, 1975, Prostaglandins.

Azapropazone - its place in the management of rheumatoid conditions.

W. Buchanan, P. Brooks, 1976, Current medical research and opinion.

Anemia associated with rheumatoid disease. Inverse correlation between erythropoiesis and both IgM and rheumatoid factor levels.

W. Buchanan, D. Chui, W. Kean, 1983, Arthritis and rheumatism.

A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

R. B. Goudie, W. Buchanan, R. N. Macsween, 1968, Clinical and experimental immunology.

Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis

N. Bellamy, W. Buchanan, P. Corey, 1988 .

Relative roles of genetic and environmental factors in the control of serum uric acid levels in normouricaemic subjects.

W. Buchanan, J. A. Boyle, W. Greig, 1967, Annals of the rheumatic diseases.

The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis.

W. Buchanan, E. Grace, J. Rosenfeld, 1987, Current medical research and opinion.

William Hunter (1718-1783).

W. Buchanan, 2003, Rheumatology.

Do oral corticosteroids cause osteoporosis in rheumatoid arthritis?

J. Anderson, W. Buchanan, J. A. Boyle, 1970, Annals of the rheumatic diseases.

Therelationship between uric acid andpotassium innormal subjects

W. Buchanan, John A. Anderson, K. Boddy, 1978 .

Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations.

W. Buchanan, W. Dick, G. H. Gray, 1978, British journal of clinical pharmacology.

Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index.

N. Bellamy, W. Buchanan, J. Campbell, 1992, The Journal of rheumatology.

Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability.

N. Bellamy, W. Buchanan, J. Campbell, 1991, Annals of the rheumatic diseases.

Method for Assessing Therapeutic Potential of Anti-inflammatory Antirheumatic Drugs in Rheumatoid Arthritis

J. Anderson, W. Buchanan, P. Lee, 1973, British medical journal.

A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.

N. Bellamy, W. Buchanan, J. Campbell, 1993, The Journal of rheumatology.

Evaluation of a simple articular index for joint tenderness in rheumatoid arthritis.

W. Buchanan, J. A. Boyle, M. K. Jasani, 1969, Annals of the rheumatic diseases.

Detection of kallikrein-like activity in inflamed synovial tissue.

W. Buchanan, S. Deodhar, I. J. Zeitlin, 1983, Archives internationales de pharmacodynamie et de therapie.

McMaster: Is This Experiment in Medical Education of Any Relevance to the Scottish Universities?

W. Buchanan, P. Rooney, W. Kean, 1983, Scottish medical journal.

Effects of aspirin, naloxone and placebo

N. Bellamy, W. Buchanan, P. Brooks, 1987, Clinical Rheumatology.

Signal measurement strategies: are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?

C. Goldsmith, N. Bellamy, W. Buchanan, 1990, Arthritis and rheumatism.

Homœopathic therapy in rheumatoid arthritis

W. Buchanan, S. Gibson, R. Gibson, 1986, British Homeopathic Journal.

The place for non-pharmaceutical therapy in chronic rheumatoid arthritis: A critical study of homœopathy

W. Buchanan, S. Gibson, R. Gibson, 1980, British Homeopathic Journal.

Penetration of sodium fusidate (Fucidin) in the synovial cavity.

W. Buchanan, W. Dick, G. Nuki, 1972, Scandinavian Journal of Rheumatology.

HLA-D region genes and susceptibility to rheumatoid arthritis.

W. Buchanan, D. Singal, M. Ye, 1997, Transplantation Proceedings.

Rheumatoid arthritis.

W. Buchanan, K. Rainsford, W. Kean, 2023, Inflammopharmacology.

NSAID and osteoarthritis--help or hindrance?

W. Buchanan, P. Brooks, S. Potter, 1982, The Journal of rheumatology.

Osteoporosis in patients with rheumatoid arthritis.

W. Buchanan, M. K. Jasani, G. Smith, 1975, Annals of the rheumatic diseases.

Bernardino Ramazzini (1633–1714) Physician of Rradesmen, and possibly one of the “Fathers” of sports medicine

W. Buchanan, 1991, Clinical Rheumatology.

Are gallstones less prevalent in rheumatoid arthritis

W. Buchanan, H. Buchanan, E. Gerecz-Simon, 1991, Clinical Rheumatology.

The heart in rheumatic disease.

W. Buchanan, 1998, Saudi medical journal.

Narcotic analgesics.

W. Buchanan, K. Rainsford, W. Kean, 2023, Inflammopharmacology.

Dr. Douglas Taylor and half a century of musculoskeletal Kelvinism

N. Bellamy, W. Buchanan, 1988, Clinical Rheumatology.

A Pilot Study of CyA in Patients with Rheumatoid Arthritis (RA)

P. Tugwell, C. Bombardier, W. Buchanan, 1985 .

Salicylates and homeopathy

W. Buchanan, W. Dick, R. Gibson, 1979 .

Are 'homeopathic' doses of oral corticosteroids effective in rheumatoid arthritis?

W. Buchanan, H. Buchanan, L. Stephen, 1988, Clinical and experimental rheumatology.

Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

N. Bellamy, W. Buchanan, J. Campbell, 1991, Journal of Rheumatology.

Rheumatic manifestations of immune deficiency.

W. Buchanan, S. J. Preston, 1989, Clinical and experimental rheumatology.

Genetic and non-genetic factors in simple goitre formation: evidence from a twin study.

W. Buchanan, J. A. Boyle, W. Greig, 1967, The Quarterly journal of medicine.

Clinical therapeutic trials.

W. Buchanan, K. Rainsford, W. Kean, 2023, Inflammopharmacology.

The treatment of acute rheumatism by salicin, by T.J. Maclagan--The Lancet, 1876.

W. Buchanan, W. Kean, 2002, The Journal of rheumatology.

Clinical, Pathologic, and Serologic Studies in Sjögren's Syndrome

W. Buchanan, J. J. Bunim, L. Sokoloff, 2020 .

Treatment of rheumatic musculoskeletal disorders.

W. Buchanan, K. Rainsford, W. Kean, 2023, Inflammopharmacology.

The contribution of William Hunter (1718–1783) to the study of bone and joint disease

W. Buchanan, D. Palmer, W. Kean, 1987, Clinical Rheumatology.

Methods of assessment used in ankylosing spondylitis clinical trials: a review.

N. Bellamy, W. Buchanan, M. R. Laurent, 1991, British journal of rheumatology.

Sjögren's syndrome beyond the eye.

W. Buchanan, S. J. Preston, M. Arnold, 1989, Australian and New Zealand journal of ophthalmology.

Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy

W. Buchanan, S. Campbell, J. A. Boyle, 1966, Journal of clinical pathology.

Liver disease inrheumatoid arthritis and Sj0gren's syndrome Prospective studyusing biochemical andserological markers ofhepatic dysfunction

W. Buchanan, K. Whaley, G. Nuki, 1975 .

The place of mefenamic acid in the treatment of rheumatoid arthritis.

W. Buchanan, M. Mavrikakis, M. M. Madkour, 1978, Scottish medical journal.

Fibroblast growth factors in scleroderma.

W. Buchanan, S. Goldstein, J. Bienenstock, 1985, The Journal of rheumatology.

The effects of morphine and nalorphine on the plasma 11-hydroxy corticosteroid response to insulin-induced hypoglycaemia in patients with rheumatoid arthritis

W. Downie, W. Buchanan, A. Shenkin, 1975 .

A short review of the relationship between intestinal permeability and inflammatory joint disease.

W. Buchanan, P. Rooney, R. Jenkins, 1990, Clinical and Experimental Rheumatology.

Sjögren's Syndrome

W. Buchanan, 1972, JAMA.